Mackenzie Financial
ANGO icon

Mackenzie Financial’s AngioDynamics ANGO Stock Holding History

Mackenzie Financial’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-77,445
Closed -$727K – 1708
2025
Q1 		$727K Buy
77,445
+13,152
+20% +$138K ﹤0.01% 1072
2024
Q4 		$589K Buy
64,293
+40,793
+174% +$300K ﹤0.01% 1099
2024
Q3 		$183K Buy
23,500
+10,230
+77% +$73.9K ﹤0.01% 1409
2024
Q2 		$80.3K Buy
+13,270
New +$81.9K ﹤0.01% 1454

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Mackenzie Financial's ANGO Position: Q2 2025 in Review

Mackenzie Financial sold out of AngioDynamics (ANGO) in Q2 2025, closing a stake of 77,445 shares — an estimated $727K sold.

Mackenzie Financial first reported a position in ANGO in Q2 2024 and held it in 4 quarters. The position peaked at $727K in Q1 2025. 150 funds tracked by Wall St. Rank hold ANGO as of Q2 2025.

  • Mackenzie Financial reported no remaining AngioDynamics position as of Q2 2025 after selling out during the quarter.
  • Mackenzie Financial sold 77,445 AngioDynamics shares in Q2 2025, an estimated $727K.
  • Mackenzie Financial first reported a position in AngioDynamics in Q2 2024 and held it in 4 quarters.
  • Mackenzie Financial's AngioDynamics position peaked at $727K in Q1 2025.
  • 150 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2025.

Based on Mackenzie Financial's 13F filing for Q2 2025, filed 13 Aug 2025.